ChinaBio® Partnering Forum 2017: Roche looks to real-world data and IT to drive partnering in China

June 5, 2017
Mark Noguchi, Global Head, Alliance and Asset Management at Roche discusses with Scrip’s Brian Yang the Swiss biotech's plan to tap into emerging IT for partnering opportunities in China. Roche has been quietly looking for partnering in Asia Pacific, tapping into China's leadership in IT and emerging artificial intelligence and machine learning technology. Facing increasing competition from biosimilars to its best-selling oncology treatment, Roche is looking at personalized healthcare, a method of using real-world data to drive research, including patient selection for clinical studies so the patients will mostly benefit from Roche medicines. With the largest population data, China could potentially become a source for medicine innovation. Roche sees that translational medicines are still a challenge in China, but that can be solved with the help of multinational drug makers. This interview was recorded at ChinaBio® Partnering Forum organized by EBD Group and ChinaBio® Group in Zhuhai, Guangdong, in May 2017.
Previous Video
ChinaBio® Partnering Forum 2017: HitGen aids China drug discovery with DNA library
ChinaBio® Partnering Forum 2017: HitGen aids China drug discovery with DNA library

Wei Chen, head of R&D for Chengdu-based HitGen describes to Scrip’s Brian Yang how the Chinese startup part...

Next Video
ChinaBio® Partnering Forum 2017: China's HEC Pharm enters America with novel IPF treatment
ChinaBio® Partnering Forum 2017: China's HEC Pharm enters America with novel IPF treatment

Tommy Lin, head of Business Development and Global Licensing for HEC Pharm outlines for Scrip’s Brian Yang ...